Variant Perception

Variant Perception

Figures converted from JPY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The variant scorecard

Variant strength 72: EPS wedge sized, sourced, tied to a specific quarter, but $19.18 consensus is already below spot (some pessimism is priced). Consensus clarity 78: sell-side has published explicit FY27 EPS / target prices and management has guided in writing. Evidence strength 74: three over-deliver data points, mechanical buyback cancellation, December 2025 moat shock — Tokyo CBD option remains unscheduled. Time to resolution: ~50 days to the Q1 print; durable variables (Shinjuku cap-rate, break-even under stress) take 18-24 months.

---

What the market actually believes — and the signal proving it is consensus

Each "market believes" claim has at least one published, named, regulated-research source. The ledger below attacks issues #1 and #3 directly; on #2 we partially concede (moat durability 65/100, brand-curator amplifier compressing); on #4 we are agnostic — tape stretching is not the same as the underwriting variable being wrong.

---

The disagreement ledger — three views that survive the five-test filter

Eight candidate disagreements were ranked; five rejected (Sogo & Seibu reactivation, regional rationalization, board governance — not sizable in 12 months; maison direct-distribution — moat tab partially concedes; tape-stretch — technicals tab cannot dismiss). The three survivors below, ranked by expected value.

How each view classifies against the eight buckets

None of the three is "the market is too pessimistic" or "high quality but undervalued". Each names a specific analytical mistake with an evidence trail and resolution path.

---

Disagreement #1 in numbers — recurring profit is the line that matters

Stripping the FY25 $76M impairment and the FY26 $66M Shin Kong gain leaves a clean operating series that has compounded modestly through the supposed "cyclical peak". Net income zig-zags on one-offs the sell-side then extrapolates.

The line the bear cluster anchors on (red) drops 19% into FY27; the line management controls (teal) is guided up 1.9% and the run-rate (blue) down only 7.6%. Consensus is reading the red line; management is operating on the teal one. The three-year track record argues the teal line prints above $520-526M and the red line above $420M — i.e., $1.22 EPS, not $1.10.

Beat magnitude narrows as the cycle matures (+55% → +9% → +5%). A +3-5% OP beat against the $511M FY27 guide lands recurring profit at $520-540M — the range $1.22 EPS underwrites. Consensus FY27 EPS $1.10 requires management to fall short for the first time in four years — possible, but base-rate-inconsistent.

The buyback compounds the wedge. $188M / 18M shares (5.12% of float) completed April 1, 2026, and the repurchased shares were cancelled — EPS denominator drops permanently. $1.10 × ~370M pre-cancellation = NI $407M; on post-cancellation ~350M, $1.10 implies NI $385M (close to guide). Cancellation alone closes ~5% of the wedge before any operating outcome.

---

Disagreement #2 in shape — the capital-return floor + the Tokyo CBD option

The market models capital return as cyclical when it is contractual through FY28, and prices the Shinjuku JR-block envelope as zero option value.

The Shinjuku JR-block is the orthogonal long-duration disagreement. Bull's $36.19 scenario by FY31 requires this option to crystallise; base case $23.09 does not. No sell-side note credits any real-estate NAV today. A May 2028 Phase II MTP cap-rate framework — or FY29 West Exit tower opening pulling forward partner-economics — would monetise. Absent that, the bear's "vision over discipline" critique ratifies.

This view has the lowest near-term resolution probability but highest tail-impact. Orthogonal to #1 — Q1 FY27 resolves #1 in 50 days; #2 takes 24+ months.

---

Disagreement #3 in numbers — the December 2025 moat test that consensus has not absorbed

The Dec 2025 shock is the cleanest in-cycle stress test since COVID. Five operators disclosed monthly numbers in the same week on the same accounting basis.

Read the December column. IMHDS duty-free (-14.2%) was middle-of-pack — the China shock hit every tax-free counter. The investment-relevant line is total sales: IMHDS -0.5% vs J. Front -1.9% / H2O -3.6% / Matsuya -11%. March shows the fastest V-shape recovery in the cohort. Consensus treats duty-free YoY as the headline; total-sales YoY is the cleaner moat signal.

---

Evidence audit — the items a PM can verify fast

Report-wide evidence items that move the variant view, with consensus vs variant read and fragility.

---

Resolution signals — observable evidence that resolves each disagreement

Each signal is observable in a filing, monthly disclosure, broker note, or scheduled MTP — with where to check it.

---

Red team — the evidence that would break each view

---

The one closing pointer